THE  ||| S:0 E:4 ||| DT
ROLE  ||| S:4 E:9 ||| NNP
OF  ||| S:9 E:12 ||| IN
REACTIVE  ||| S:12 E:21 ||| NNP
OXYGEN  ||| S:21 E:28 ||| NNP
SPECIES  ||| S:28 E:36 ||| NNP
IN  ||| S:36 E:39 ||| IN
TUMOR  ||| S:39 E:45 ||| NNP
CELLS  ||| S:45 E:51 ||| NNP
APOPTOSIS  ||| S:51 E:61 ||| NNP
INDUCED  ||| S:61 E:69 ||| NNP
BY  ||| S:69 E:72 ||| NNP
LANDOMYCIN  ||| S:72 E:83 ||| NNP
A  ||| S:83 E:85 ||| NNP
Landomycin  ||| S:85 E:96 ||| NNP
A  ||| S:96 E:98 ||| NNP
( ||| S:98 E:99 ||| -LRB-
LA ||| S:99 E:101 ||| NNP
)  ||| S:101 E:103 ||| -RRB-
is  ||| S:103 E:106 ||| VBZ
a  ||| S:106 E:108 ||| DT
new  ||| S:108 E:112 ||| JJ
antitumor  ||| S:112 E:122 ||| JJ
antibiotic  ||| S:122 E:133 ||| NN
of  ||| S:133 E:136 ||| IN
angucycline  ||| S:136 E:148 ||| JJ
group ||| S:148 E:153 ||| NN
,  ||| S:153 E:155 ||| ,
possessing  ||| S:155 E:166 ||| VBG
high  ||| S:166 E:171 ||| JJ
antitumor  ||| S:171 E:181 ||| JJ
activity  ||| S:181 E:190 ||| NN
against  ||| S:190 E:198 ||| IN
cancer  ||| S:198 E:205 ||| NN
cells  ||| S:205 E:211 ||| NNS
of  ||| S:211 E:214 ||| IN
different  ||| S:214 E:224 ||| JJ
origin ||| S:224 E:230 ||| NN
,  ||| S:230 E:232 ||| ,
which  ||| S:232 E:238 ||| WDT
induces  ||| S:238 E:246 ||| VBZ
early  ||| S:246 E:252 ||| JJ
apoptosis  ||| S:252 E:262 ||| NN
in  ||| S:262 E:265 ||| IN
target  ||| S:265 E:272 ||| NN
cells ||| S:272 E:277 ||| NNS
.  ||| S:277 E:279 ||| .
It  ||| S:279 E:282 ||| PRP
was  ||| S:282 E:286 ||| VBD
shown  ||| S:286 E:292 ||| VBN
that  ||| S:292 E:297 ||| IN
under  ||| S:297 E:303 ||| IN
LA  ||| S:303 E:306 ||| NNP
action  ||| S:306 E:313 ||| NN
the  ||| S:313 E:317 ||| DT
level  ||| S:317 E:323 ||| NN
of  ||| S:323 E:326 ||| IN
reactive  ||| S:326 E:335 ||| JJ
oxygen  ||| S:335 E:342 ||| NN
species  ||| S:342 E:350 ||| NNS
( ||| S:350 E:351 ||| -LRB-
ROS ||| S:351 E:354 ||| NNP
)  ||| S:354 E:356 ||| -RRB-
in  ||| S:356 E:359 ||| IN
human  ||| S:359 E:365 ||| JJ
T-leukemia  ||| S:365 E:376 ||| JJ
cells  ||| S:376 E:382 ||| NNS
had  ||| S:382 E:386 ||| VBD
increased  ||| S:386 E:396 ||| VBN
5.6  ||| S:396 E:400 ||| CD
times  ||| S:400 E:406 ||| NNS
in  ||| S:406 E:409 ||| IN
comparison  ||| S:409 E:420 ||| NN
to  ||| S:420 E:423 ||| TO
control  ||| S:423 E:431 ||| VB
already  ||| S:431 E:439 ||| RB
at  ||| S:439 E:442 ||| IN
the  ||| S:442 E:446 ||| DT
1st  ||| S:446 E:450 ||| CD
hour  ||| S:450 E:455 ||| NN
after  ||| S:455 E:461 ||| IN
the  ||| S:461 E:465 ||| DT
addition  ||| S:465 E:474 ||| NN
of  ||| S:474 E:477 ||| IN
studied  ||| S:477 E:485 ||| JJ
antibiotic  ||| S:485 E:496 ||| NN
to  ||| S:496 E:499 ||| TO
the  ||| S:499 E:503 ||| DT
culture  ||| S:503 E:511 ||| NN
medium ||| S:511 E:517 ||| NN
.  ||| S:517 E:519 ||| .
At  ||| S:519 E:522 ||| IN
the  ||| S:522 E:526 ||| DT
6th  ||| S:526 E:530 ||| JJ
hour  ||| S:530 E:535 ||| NN
after  ||| S:535 E:541 ||| IN
incubation  ||| S:541 E:552 ||| NN
of  ||| S:552 E:555 ||| IN
cells  ||| S:555 E:561 ||| NNS
with  ||| S:561 E:566 ||| IN
LA  ||| S:566 E:569 ||| NNP
the  ||| S:569 E:573 ||| DT
nucleosomal  ||| S:573 E:585 ||| JJ
DNA  ||| S:585 E:589 ||| NN
cleavage ||| S:589 E:597 ||| NN
,  ||| S:597 E:599 ||| ,
chromatin  ||| S:599 E:609 ||| JJ
condensation  ||| S:609 E:622 ||| NN
and  ||| S:622 E:626 ||| CC
nucleus  ||| S:626 E:634 ||| JJ
fragmentation  ||| S:634 E:648 ||| NN
were  ||| S:648 E:653 ||| VBD
observed ||| S:653 E:661 ||| VBN
,  ||| S:661 E:663 ||| ,
indicating  ||| S:663 E:674 ||| VBG
apoptotic  ||| S:674 E:684 ||| JJ
cell  ||| S:684 E:689 ||| NN
death ||| S:689 E:694 ||| NN
.  ||| S:694 E:696 ||| .
Catalase  ||| S:696 E:705 ||| NNP
( ||| S:705 E:706 ||| -LRB-
scavenger  ||| S:706 E:716 ||| NN
of  ||| S:716 E:719 ||| IN
hydrogen  ||| S:719 E:728 ||| JJ
peroxide ||| S:728 E:736 ||| NN
) ||| S:736 E:737 ||| -RRB-
,  ||| S:737 E:739 ||| ,
mannitol  ||| S:739 E:748 ||| NNS
( ||| S:748 E:749 ||| -LRB-
scavenger  ||| S:749 E:759 ||| NN
of  ||| S:759 E:762 ||| IN
hydroxyl  ||| S:762 E:771 ||| JJ
radicals ||| S:771 E:779 ||| NNS
)  ||| S:779 E:781 ||| -RRB-
and  ||| S:781 E:785 ||| CC
superoxide  ||| S:785 E:796 ||| JJ
dismutase  ||| S:796 E:806 ||| NNS
( ||| S:806 E:807 ||| -LRB-
scavenger  ||| S:807 E:817 ||| NN
of  ||| S:817 E:820 ||| IN
superoxide  ||| S:820 E:831 ||| JJ
radicals ||| S:831 E:839 ||| NNS
)  ||| S:839 E:841 ||| -RRB-
reduced  ||| S:841 E:849 ||| VBD
the  ||| S:849 E:853 ||| DT
level  ||| S:853 E:859 ||| NN
of  ||| S:859 E:862 ||| IN
ROS  ||| S:862 E:866 ||| NNP
production  ||| S:866 E:877 ||| NN
under  ||| S:877 E:883 ||| IN
LA ||| S:883 E:885 ||| NNP
,  ||| S:885 E:887 ||| ,
suggesting  ||| S:887 E:898 ||| VBG
the  ||| S:898 E:902 ||| DT
generation  ||| S:902 E:913 ||| NN
of  ||| S:913 E:916 ||| IN
H2O2 ||| S:916 E:920 ||| NNP
,  ||| S:920 E:922 ||| ,
OH*  ||| S:922 E:926 ||| NNP
and  ||| S:926 E:930 ||| CC
O2-  ||| S:930 E:934 ||| CD
radicals ||| S:934 E:942 ||| NNS
,  ||| S:942 E:944 ||| ,
respectively ||| S:944 E:956 ||| RB
.  ||| S:956 E:958 ||| .
It  ||| S:958 E:961 ||| PRP
was  ||| S:961 E:965 ||| VBD
revealed  ||| S:965 E:974 ||| VBN
that  ||| S:974 E:979 ||| IN
catalase  ||| S:979 E:988 ||| NN
and  ||| S:988 E:992 ||| CC
mannitol  ||| S:992 E:1001 ||| VBP
effectively  ||| S:1001 E:1013 ||| RB
inhibited  ||| S:1013 E:1023 ||| VBD
LA-mediated  ||| S:1023 E:1035 ||| JJ
tumor  ||| S:1035 E:1041 ||| NN
cell  ||| S:1041 E:1046 ||| NN
death ||| S:1046 E:1051 ||| NN
,  ||| S:1051 E:1053 ||| ,
increasing  ||| S:1053 E:1064 ||| VBG
2.5  ||| S:1064 E:1068 ||| CD
times  ||| S:1068 E:1074 ||| NNS
the  ||| S:1074 E:1078 ||| DT
percentage  ||| S:1078 E:1089 ||| NN
of  ||| S:1089 E:1092 ||| IN
alive  ||| S:1092 E:1098 ||| JJ
cells  ||| S:1098 E:1104 ||| NNS
in  ||| S:1104 E:1107 ||| IN
comparison  ||| S:1107 E:1118 ||| NN
to  ||| S:1118 E:1121 ||| TO
LA ||| S:1121 E:1123 ||| NNP
.  ||| S:1123 E:1125 ||| .
However ||| S:1125 E:1132 ||| RB
,  ||| S:1132 E:1134 ||| ,
superoxide  ||| S:1134 E:1145 ||| JJ
dismutase  ||| S:1145 E:1155 ||| NN
had  ||| S:1155 E:1159 ||| VBD
no  ||| S:1159 E:1162 ||| DT
significant  ||| S:1162 E:1174 ||| JJ
inhibitory  ||| S:1174 E:1185 ||| JJ
effect  ||| S:1185 E:1192 ||| NN
on  ||| S:1192 E:1195 ||| IN
cytotoxic  ||| S:1195 E:1205 ||| JJ
activity  ||| S:1205 E:1214 ||| NN
of  ||| S:1214 E:1217 ||| IN
LA ||| S:1217 E:1219 ||| NNP
,  ||| S:1219 E:1221 ||| ,
indicating  ||| S:1221 E:1232 ||| VBG
the  ||| S:1232 E:1236 ||| DT
minor  ||| S:1236 E:1242 ||| JJ
role  ||| S:1242 E:1247 ||| NN
of  ||| S:1247 E:1250 ||| IN
superoxide  ||| S:1250 E:1261 ||| JJ
anions  ||| S:1261 E:1268 ||| NN
in  ||| S:1268 E:1271 ||| IN
the  ||| S:1271 E:1275 ||| DT
implementation  ||| S:1275 E:1290 ||| NN
of  ||| S:1290 E:1293 ||| IN
antitumor  ||| S:1293 E:1303 ||| JJ
activity  ||| S:1303 E:1312 ||| NN
of  ||| S:1312 E:1315 ||| IN
this  ||| S:1315 E:1320 ||| DT
antibiotic ||| S:1320 E:1330 ||| NN
.  ||| S:1330 E:1332 ||| .
Combination  ||| S:1332 E:1344 ||| NN
of  ||| S:1344 E:1347 ||| IN
catalase ||| S:1347 E:1355 ||| NN
,  ||| S:1355 E:1357 ||| ,
mannitol  ||| S:1357 E:1366 ||| NN
and  ||| S:1366 E:1370 ||| CC
superoxide  ||| S:1370 E:1381 ||| JJ
dismutase  ||| S:1381 E:1391 ||| NN
with  ||| S:1391 E:1396 ||| IN
LA  ||| S:1396 E:1399 ||| NNP
increased  ||| S:1399 E:1409 ||| VBD
4-fold  ||| S:1409 E:1416 ||| CD
the  ||| S:1416 E:1420 ||| DT
percentage  ||| S:1420 E:1431 ||| NN
of  ||| S:1431 E:1434 ||| IN
alive  ||| S:1434 E:1440 ||| JJ
cells  ||| S:1440 E:1446 ||| NNS
in  ||| S:1446 E:1449 ||| IN
comparison  ||| S:1449 E:1460 ||| NN
to  ||| S:1460 E:1463 ||| TO
the  ||| S:1463 E:1467 ||| DT
action  ||| S:1467 E:1474 ||| NN
of  ||| S:1474 E:1477 ||| IN
LA ||| S:1477 E:1479 ||| NNP
.  ||| S:1479 E:1481 ||| .
Dynamics  ||| S:1481 E:1490 ||| NNP
of  ||| S:1490 E:1493 ||| IN
ROS  ||| S:1493 E:1497 ||| NNP
formation  ||| S:1497 E:1507 ||| NN
confirms  ||| S:1507 E:1516 ||| VBZ
that  ||| S:1516 E:1521 ||| IN
the  ||| S:1521 E:1525 ||| DT
increase  ||| S:1525 E:1534 ||| NN
of  ||| S:1534 E:1537 ||| IN
ROS  ||| S:1537 E:1541 ||| NNP
is  ||| S:1541 E:1544 ||| VBZ
a  ||| S:1544 E:1546 ||| DT
very  ||| S:1546 E:1551 ||| RB
rapid  ||| S:1551 E:1557 ||| JJ
process ||| S:1557 E:1564 ||| NN
,  ||| S:1564 E:1566 ||| ,
but  ||| S:1566 E:1570 ||| CC
at  ||| S:1570 E:1573 ||| IN
the  ||| S:1573 E:1577 ||| DT
same  ||| S:1577 E:1582 ||| JJ
time  ||| S:1582 E:1587 ||| NN
it  ||| S:1587 E:1590 ||| PRP
is  ||| S:1590 E:1593 ||| VBZ
not  ||| S:1593 E:1597 ||| RB
a  ||| S:1597 E:1599 ||| DT
direct  ||| S:1599 E:1606 ||| JJ
consequence  ||| S:1606 E:1618 ||| NN
of  ||| S:1618 E:1621 ||| IN
apoptosis  ||| S:1621 E:1631 ||| JJ
triggering ||| S:1631 E:1641 ||| NN
,  ||| S:1641 E:1643 ||| ,
mediated  ||| S:1643 E:1652 ||| VBG
by  ||| S:1652 E:1655 ||| IN
mitochondria ||| S:1655 E:1667 ||| NN
.  ||| S:1667 E:1669 ||| .
